NCT07478354 Heart Institute BioRepository (HIBR) for Pediatric Heart Disease
| NCT ID | NCT07478354 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Medical Center, Cincinnati |
| Condition | Cardiovascular Diseases (CVD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2012-01-27 |
| Primary Completion | 2050-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2012-01-27 with a primary completion date of 2050-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this protocol is to redefine the Heart Institute BioRepository (HIBR) to facilitate Investigator-initiated and programmatic basic, translational, clinical and outcomes research. For the purposes of this protocol, "tissue" will refer to any gross specimen obtained from a patient, including but not limited to blood, cardiovascular tissue, urine, saliva, and other tissues and bodily fluids, including explanted non-human prosthetics or grafts. In this context, "tissue" is synonymous with "sample" or "specimen." A "BioRepository" functions to systematically collect, maintain and govern tissue specimens.
Eligibility Criteria
Inclusion Criteria * Any fetus, child or adult at risk of or diagnosed with Pediatric Heart Disease (PHD) or Cardiovascular Disease (CVD) * Any HI patient, including the following types of encounters: Surgery or Cardiac Catheterization or Advanced Imaging encounters, Inpatient, including Cardiology service, consultation patients and Fetal Delivery, and Outpatient, including all HI-associated clinics and consultation services * Any female carrying a fetus with a suspected cardiac diagnosis Exclusion Criteria * Legal guardian unauthorized to consent * Families who choose Palliative care during pregnancy
Contact & Investigator
Jeffrey Alten
PRINCIPAL INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Frequently Asked Questions
Who can join the NCT07478354 clinical trial?
This trial is open to participants of all sexes, studying Cardiovascular Diseases (CVD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07478354 currently recruiting?
Yes, NCT07478354 is actively recruiting participants. Contact the research team at HIBioRepository@cchmc.org for enrollment information.
Where is the NCT07478354 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT07478354 clinical trial?
NCT07478354 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Jeffrey Alten at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 5,000 participants.